Results
2
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Pharming Group
Market Cap: €872.2m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€1.27
7D
7.1%
1Y
79.0%
Vivoryon Therapeutics
Market Cap: €42.9m
Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.
VVY
€1.64
7D
-2.6%
1Y
-31.5%